Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

NCT02500316 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Growth Hormone Deficiency (GHD)

Interventions

DRUG: MOD-4023

Sponsor

OPKO Health, Inc.